4-77607750-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001371558.1(CXCL13):c.112G>A(p.Glu38Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000198 in 1,613,352 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001371558.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CXCL13 | ENST00000682537.1 | c.112G>A | p.Glu38Lys | missense_variant | 2/4 | NM_001371558.1 | ENSP00000507688.1 | |||
CXCL13 | ENST00000286758.4 | c.112G>A | p.Glu38Lys | missense_variant | 3/5 | 1 | ENSP00000286758.4 | |||
CXCL13 | ENST00000506590.1 | n.146G>A | non_coding_transcript_exon_variant | 2/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151718Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251356Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135836
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1461634Hom.: 0 Cov.: 30 AF XY: 0.0000248 AC XY: 18AN XY: 727132
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151718Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74106
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 24, 2024 | The c.112G>A (p.E38K) alteration is located in exon 3 (coding exon 2) of the CXCL13 gene. This alteration results from a G to A substitution at nucleotide position 112, causing the glutamic acid (E) at amino acid position 38 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at